| scholarly article | Q13442814 |
| P50 | author | Rao Zihe | Q9030008 |
| P2093 | author name string | Zhiyong Lou | |
| Wenyan Fu | |||
| Yajun Guo | |||
| Yuna Sun | |||
| Bohua Li | |||
| Sheng Hou | |||
| Weizhu Qian | |||
| Huaizu Guo | |||
| Xiaoze Wang | |||
| Shi Hu | |||
| Yanchun Meng | |||
| Weili Yang | |||
| P2860 | cites work | Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association | Q24297029 |
| Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha | Q24307630 | ||
| Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains | Q24307661 | ||
| Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab | Q27640593 | ||
| The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors | Q27640631 | ||
| ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor | Q27657234 | ||
| Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor | Q27664092 | ||
| Insights into HER2 signaling from step-by-step optimization of anti-HER2 antibodies | Q27683825 | ||
| Cell signaling by receptor tyrosine kinases | Q27860474 | ||
| Untangling the ErbB signalling network | Q27860884 | ||
| An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors | Q28207289 | ||
| The EGF receptor family: spearheading a merger of signaling and therapeutics | Q28289369 | ||
| Ligand-induced, receptor-mediated dimerization and activation of EGF receptor | Q28646134 | ||
| ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer | Q28678776 | ||
| Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers | Q28679173 | ||
| EGF-ERBB signalling: towards the systems level | Q29619032 | ||
| Epidermal growth factor receptor: mechanisms of activation and signalling. | Q34185055 | ||
| Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems | Q34292599 | ||
| Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex | Q34314489 | ||
| The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors | Q36334739 | ||
| Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. | Q36556065 | ||
| The kinase domain and membrane localization determine intracellular interactions between epidermal growth factor receptors | Q38298693 | ||
| All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells. | Q39941394 | ||
| Flow cytometric FRET analysis of erbB receptor interaction on a cell-by-cell basis | Q39966019 | ||
| Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling | Q40015717 | ||
| ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface | Q40540606 | ||
| The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions | Q41554100 | ||
| Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth | Q44120544 | ||
| A novel proximity assay for the detection of proteins and protein complexes: quantitation of HER1 and HER2 total protein expression and homodimerization in formalin-fixed, paraffin-embedded cell lines and breast cancer tissue. | Q51824154 | ||
| HER2/Neu: mechanisms of dimerization/oligomerization | Q77628599 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1695-1706 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Molecular architecture of the ErbB2 extracellular domain homodimer | |
| P478 | volume | 6 |
| Q36314931 | A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands. |
| Q92890062 | A germline alteration of ERBB2 increases the risk of breast cancer in Chinese Han women with a familial history of malignant tumors |
| Q36114109 | An anti-ErbB2 fully human antibody circumvents trastuzumab resistance |
| Q38703210 | Combating acquired resistance to trastuzumab by an anti-ErbB2 fully human antibody |
| Q37709032 | Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1. |
| Q55000376 | Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV. |
| Q38695293 | Liquid-phase electron microscopy of molecular drug response in breast cancer cells reveals irresponsive cell subpopulations related to lack of HER2 homodimers |
| Q57105786 | Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer |
| Q33364587 | Pertuzumab and breast cancer: another piece in the anti-HER2 puzzle |
| Q38573858 | Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy |
| Q40975738 | Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization. |
| Q64084185 | The Effects of Pertuzumab and Its Combination with Trastuzumab on HER2 Homodimerization and Phosphorylation |
| Q92908478 | Visualisation of HER2 homodimers in single cells from HER2 overexpressing primary formalin fixed paraffin embedded tumour tissue |
Search more.